的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300550 证券简称：和仁科技 公告编号：2026-002 浙江和仁科技股份有限公司 关于已披露日常经营合同收到中标通知书 根据中标报价测算，预计公司此次中标金额 83,800,000 元,约占公司最近一 期经审计的 2024 年度营业收入的 20.64%。上述中标预计对公司 2026 年经营业 绩有积极影响，且不影响公司经营的独立性，实际影响以项目实施完成情况为准。 三、风险提示 截至公告日，该项目尚未签订正式合同，项目具体内容以签署后的正式合同 条款为准，待正式合同签订后公司将履行相应的信息披露程序，敬请广大投资者 注意投资风险。 浙江和仁科技股份有限公司董事会 2026 年 3 月 18 日 2、招标人：中国建筑一局（集团）有限公司 3、招标代理机构：重庆联盛建设项目管理有限公司 4、项目中标金额报价：83,800,000 元 浙江和仁科技股份有限公司（以下简称"和仁科技"或"公司"）于 2026 年 3 月 4 日披露了《关于日常经营合同预中标的提示性公告》（详见巨潮资讯网 htt ...

Major Announcements - Farsen announced that it does not engage in "special optical fibers," "fiber sensing," or related businesses, and may apply for a trading suspension if stock prices continue to rise [1] - COSCO Shipping has suspended new bookings for related routes due to escalating conflicts in the Middle East, affecting several countries [2] Financial Performance - Muxi Co. expects a net loss of 90.76 million to 182 million yuan in Q1 2026, but revenue is projected to grow by 24.84% to 87.26% year-on-year [3] - Shanghai Electric received approval for two offshore wind power projects, which will enhance its green transition and increase clean energy share [4] - Xiamen Tungsten's revenue for January-February 2026 is expected to grow by 60% to 110% year-on-year, driven by rising raw material prices and increased sales [8] - Qiangyi Co. reported a 157.9% year-on-year increase in revenue for January-February 2026, attributed to strong demand in AI computing and the semiconductor industry [9] - Aerospace Intelligence reported a net profit of 881 million yuan for 2025, a year-on-year increase of 11.24% [10] - Yutong Bus sold 1,806 units in February 2026, a 14.96% increase year-on-year [11] Corporate Actions - China National Offshore Oil Corporation has cumulatively increased its stake in the company by 402.79 million yuan [16] - Huayuan Bio announced a temporary shutdown of its cholesterol production line for maintenance, expected to last no more than 45 days [7] - Zhi Gong Technology's shareholder plans to reduce its stake by up to 1.35% due to funding needs [14]

证券代码：300550 证券简称：和仁科技 公告编号：2026-001 浙江和仁科技股份有限公司 关于日常经营合同预中标的提示性公告 浙江和仁科技股份有限公司（以下简称"和仁科技"或"公司"）获悉中国 招标投标公共服务平台（网址：http://www.cebpubservice.com/）于 2026 年 3 月 4 日发布"江北区人民医院新建工程信息化软件系统采购项目中标结果公告"， 经评标委员会评审，浙江和仁科技股份有限公司为"江北区人民医院新建工程信 息化软件系统采购项目"的中标人。现将相关中标情况提示如下： 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、主要内容 公 示 网 站 ： 中 国 招 标 投 标 公 共 服 务 平 台 （ 网 址 ： http://www.cebpubservice.com/） 中标项目：江北区人民医院新建工程信息化软件系统采购项目。 项目中标金额报价：83,800,000 元。实际金额依据双方后续签订的合同为 准。 招标人：中国建筑一局（集团）有限公司。 防范投资风险。 特此公告。 浙江和仁科技股份有限公司董事会 2 ...

Group 1 - Zhejiang Heren Technology Co., Ltd. won a procurement project from Shangluo Central Hospital with a bid amount of 1.46 million yuan [1][2][3] Group 2 - Heren Technology (300550.SZ) reported a revenue of 406 million yuan for 2024, with a revenue growth rate of -7.57% [2][3] - The net profit attributable to the parent company for 2024 was 39 million yuan, with a net profit growth rate of 0.46% [2][3] - The return on equity (ROE) for the company was 3.59% [2][3] - In the first half of 2025, the company reported a revenue of 159 million yuan, with a revenue growth rate of -0.99% [2][3] - The net profit attributable to the parent company for the first half of 2025 was -4 million yuan, with a net profit growth rate of 75.44% [2][3] - The company operates in the information technology industry, with its main product types being professional consulting services [2][3] - The revenue composition for 2024 included clinical medical management information systems (62.14%), digital scene application systems (24.62%), and others (13.25%) [2][3]

Core Viewpoint - The company, Heren Technology (300550), has shown a mixed financial performance with a slight decline in revenue but significant growth in net profit for the first three quarters of 2025 [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue was 263 million yuan, a year-on-year decrease of 0.33% [2]. - The net profit attributable to shareholders was 12.94 million yuan, a year-on-year increase of 1292.86% [2]. - The non-recurring net profit was 10.93 million yuan, a year-on-year increase of 1124.98% [2]. - In Q3 2025, the company's quarterly main revenue was 105 million yuan, a year-on-year increase of 0.7% [2]. - The quarterly net profit attributable to shareholders was 16.46 million yuan, a year-on-year increase of 7.87% [2]. - The quarterly non-recurring net profit was 15.34 million yuan, a year-on-year increase of 2.87% [2]. - The company's debt ratio was 22.73%, with investment income of 904,700 yuan and financial expenses of -2.65 million yuan [2]. - The gross profit margin was 47.37% [2]. Business Overview - Heren Technology specializes in the research, sales, implementation integration, and service support of medical information systems and digital application systems [2]. - The company provides comprehensive solution services for data collection, integration, processing, storage, transmission, sharing, and application for medical institutions and health management organizations [2]. - The main business segments include medical information systems and digital application systems [2].

Core Insights - The stock of HeRen Technology (300550) closed at 14.13 yuan on February 9, 2026, with a 1.22% increase and a turnover rate of 1.49% [1] - The company reported a net outflow of 149.43 thousand yuan from main funds, accounting for 2.71% of total turnover, while retail investors experienced a net outflow of 99.11 thousand yuan, representing 1.8% of total turnover [1] Financial Performance - For the first three quarters of 2025, HeRen Technology reported a main revenue of 263 million yuan, a slight decrease of 0.33% year-on-year [2] - The net profit attributable to shareholders was 12.94 million yuan, showing a significant increase of 1292.86% year-on-year [2] - The non-recurring net profit was 10.93 million yuan, up 1124.98% year-on-year [2] - In Q3 2025, the company achieved a quarterly main revenue of 105 million yuan, an increase of 0.7% year-on-year [2] - The quarterly net profit attributable to shareholders was 16.46 million yuan, reflecting a year-on-year increase of 7.87% [2] - The quarterly non-recurring net profit was 15.34 million yuan, up 2.87% year-on-year [2] - The company's debt ratio stands at 22.73%, with investment income of 904.7 thousand yuan and financial expenses of -2.6464 million yuan [2] - The gross profit margin is reported at 47.37% [2] Business Overview - HeRen Technology specializes in the research, sales, implementation integration, and service support of medical information systems and digital application systems [2] - The company provides comprehensive solutions for data collection, integration, processing, storage, transmission, sharing, and application for medical institutions and health management organizations [2] - The main business segments include medical information systems and digital application systems [2]

Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of HeRen Technology (300550) as of February 5, 2026, showing a slight decline in stock price and mixed capital flow [1] - HeRen Technology reported a main revenue of 263 million yuan for the first three quarters of 2025, a year-on-year decrease of 0.33%, while net profit attributable to shareholders increased significantly by 1292.86% to 12.94 million yuan [1] - The company's third-quarter performance showed a main revenue of 105 million yuan, a year-on-year increase of 0.7%, and a net profit of 16.46 million yuan, up 7.87% year-on-year [1] Group 2 - The company operates primarily in the medical information systems and digital application systems sectors, providing comprehensive solutions for data collection, integration, processing, storage, transmission, sharing, and application for medical institutions [1] - The financial metrics include a debt ratio of 22.73%, investment income of 904,700 yuan, financial expenses of -2.65 million yuan, and a gross profit margin of 47.37% [1] - Capital flow data indicates a net outflow of 4.5 million yuan from main funds, while retail investors saw a net inflow of 2.99 million yuan, reflecting varied investor sentiment [1]

Group 1 - The core viewpoint of the article highlights the recent performance of HeRen Technology (300550), which saw a stock price drop of 4.19% to 14.65 yuan as of January 28, 2026, with a trading volume of 59,300 hands and a total transaction amount of 88.22 million yuan [1] - The company reported a main revenue of 263 million yuan for the first three quarters of 2025, a slight decrease of 0.33% year-on-year, while the net profit attributable to shareholders increased significantly by 1292.86% to 12.94 million yuan [2] - In Q3 2025, the company achieved a quarterly main revenue of 105 million yuan, reflecting a year-on-year increase of 0.7%, and a net profit of 16.46 million yuan, up 7.87% year-on-year [2] Group 2 - HeRen Technology specializes in the development, sales, implementation integration, and service support of medical information systems and digital application systems, providing comprehensive solutions for data collection, integration, processing, storage, transmission, sharing, and application in healthcare institutions [2] - The company's debt ratio stands at 22.73%, with investment income of 904,700 yuan and financial expenses of -2.65 million yuan, indicating a healthy financial position [2] - The gross profit margin for HeRen Technology is reported at 47.37%, showcasing the company's efficiency in managing its costs relative to its revenues [2]

Core Viewpoint - The company, Heren Technology (300550), experienced a slight decline in stock price and mixed capital flow on January 22, 2026, with a focus on its financial performance and business operations in the medical information systems sector [1][2]. Financial Performance - For the first three quarters of 2025, Heren Technology reported a main revenue of 263 million yuan, a year-on-year decrease of 0.33% [2]. - The net profit attributable to shareholders was 12.94 million yuan, showing a significant year-on-year increase of 1292.86% [2]. - The non-recurring net profit was 10.93 million yuan, up 1124.98% year-on-year [2]. - In Q3 2025, the company achieved a quarterly main revenue of 105 million yuan, reflecting a year-on-year increase of 0.7% [2]. - The quarterly net profit attributable to shareholders was 16.46 million yuan, up 7.87% year-on-year [2]. - The quarterly non-recurring net profit was 15.34 million yuan, an increase of 2.87% year-on-year [2]. - The company's debt ratio stood at 22.73%, with investment income of 904,700 yuan and financial expenses of -2.65 million yuan [2]. - The gross profit margin was reported at 47.37% [2]. Business Overview - Heren Technology specializes in the research, sales, implementation integration, and service support of medical information systems and digital application systems [2]. - The company's main business is divided into two parts: medical information systems and digital application systems, providing comprehensive solutions for data collection, integration, processing, storage, transmission, sharing, and application for medical institutions [2].

Group 1 - The core viewpoint of the article highlights the recent performance of HeRen Technology (300550), noting a stock price decline of 3.66% to 15.27 yuan as of January 16, 2026, with a trading volume of 76,800 hands and a total transaction amount of 118 million yuan [1] - The company reported a main revenue of 263 million yuan for the first three quarters of 2025, showing a slight decrease of 0.33% year-on-year, while the net profit attributable to shareholders increased significantly by 1292.86% to 12.94 million yuan [2] - In Q3 2025, the company achieved a quarterly main revenue of 105 million yuan, reflecting a year-on-year increase of 0.7%, and a net profit of 16.46 million yuan, up by 7.87% year-on-year [2] Group 2 - HeRen Technology specializes in the research, sales, implementation integration, and service support of medical information systems and digital application systems, providing comprehensive solutions for data collection, integration, processing, storage, transmission, sharing, and application in healthcare institutions [2] - The company's main business is divided into two parts: medical information systems and digital application systems [2] - The financial metrics include a debt ratio of 22.73%, investment income of 904,700 yuan, financial expenses of -2.6464 million yuan, and a gross profit margin of 47.37% [2]